Implementing evidence-based teen pregnancy prevention interventions in a communitywide initiative
In the overall initiative, state and community organizations increased the number of youth reached in targeted communities from 4,304 in 2012 to 12,024 in 2013 and 19,334 in 2014, for a total of 35,662 youth reached. Preliminary findings show that communities that reached larger numbers of youth partnered with schools and organizations with greater access to youth. In San Antonio, lead grantee organization UT Teen Health implemented EBIs at 7 high schools and 3 middle schools located in five school districts. Community mobilization and stakeholder education played integral roles in garnering community support and expanding EBIs in San Antonio public schools; youth participation expanded from 420 in 2012 to 2,567 in 2013 and 3,926 in 2014.
Results indicate that engaging schools to implement EBIs is an important strategy for reaching youth, and integrating stakeholder/community mobilization efforts helps to garner community support and expand participation in EBIs in schools.
Learning Areas:Implementation of health education strategies, interventions and programs
Describe factors that are important to address the implementation of evidence-based teen pregnancy prevention interventions. Discuss communitywide strategies to support the implementation of evidence-based teen pregnancy prevention interventions in communities. Describe community mobilization and stakeholder education strategies used in one community to implement evidence-based teen pregnancy prevention interventions in schools. Discuss increases in youth reached by evidence-based teen pregnancy prevention interventions in communitywide initiatives.
Keyword(s): Teen Pregnancy, Evidence-Based Practice
Qualified on the content I am responsible for because: I am a project officer on the OAH/CDC community-wide teen pregnancy prevention initiative overseeing communities in the United States.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.